Literature DB >> 24314082

Agonist leukadherin-1 increases CD11b/CD18-dependent adhesion via membrane tethers.

Emrah Celik1, Mohd Hafeez Faridi, Vinay Kumar, Shashank Deep, Vincent T Moy, Vineet Gupta.   

Abstract

Integrin CD11b/CD18 is a key adhesion receptor that mediates leukocyte migration and immune functions. Leukadherin-1 (LA1) is a small molecule agonist that enhances CD11b/CD18-dependent cell adhesion to its ligand ICAM-1. Here, we used single-molecule force spectroscopy to investigate the biophysical mechanism by which LA1-activated CD11b/CD18 mediates leukocyte adhesion. Between the two distinct populations of CD11b/CD18:ICAM-1 complex that participate in cell adhesion, the cytoskeleton(CSK)-anchored elastic elements and the membrane tethers, we found that LA1 enhanced binding of CD11b/CD18 on K562 cells to ICAM-1 via the formation of long membrane tethers, whereas Mn(2+) additionally increased ICAM-1 binding via CSK-anchored bonds. LA1 activated wild-type and LFA1(-/-) neutrophils also showed longer detachment distances and time from ICAM-1-coated atomic force microscopy tips, but significantly lower detachment force, as compared to the Mn(2+)-activated cells, confirming that LA1 primarily increased membrane-tether bonds to enhance CD11b/CD18:ICAM-1 binding, whereas Mn(2+) induced additional CSK-anchored bond formation. The results suggest that the two types of agonists differentially activate integrins and couple them to the cellular machinery, providing what we feel are new insights into signal mechanotransduction by such agents.
Copyright © 2013 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24314082      PMCID: PMC3853324          DOI: 10.1016/j.bpj.2013.10.020

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  46 in total

1.  Functional analysis of the beta 2 integrins.

Authors:  R Li; M A Arnaout
Journal:  Methods Mol Biol       Date:  1999

2.  Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration.

Authors:  Z M Ding; J E Babensee; S I Simon; H Lu; J L Perrard; D C Bullard; X Y Dai; S K Bromley; M L Dustin; M L Entman; C W Smith; C M Ballantyne
Journal:  J Immunol       Date:  1999-11-01       Impact factor: 5.422

Review 3.  Targeting leukocyte integrins in human diseases.

Authors:  Karyn Yonekawa; John M Harlan
Journal:  J Leukoc Biol       Date:  2004-11-17       Impact factor: 4.962

4.  Anti-ICAM-1 monoclonal antibody R6.5 (Enlimomab) promotes activation of neutrophils in whole blood.

Authors:  J Vuorte; P J Lindsberg; M Kaste; S Meri; S E Jansson; R Rothlein; H Repo
Journal:  J Immunol       Date:  1999-02-15       Impact factor: 5.422

5.  Solvent-accessible residues on the metal ion-dependent adhesion site face of integrin CR3 mediate its binding to the neutrophil inhibitory factor.

Authors:  P Rieu; T Sugimori; D L Griffith; M A Arnaout
Journal:  J Biol Chem       Date:  1996-07-05       Impact factor: 5.157

6.  A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits.

Authors:  C Rogers; E R Edelman; D I Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

7.  Inhibition of neutrophil adherence improves postischemic ventricular performance of the neonatal heart.

Authors:  I Wilson; A M Gillinov; W E Curtis; J DiNatale; R M Burch; T J Gardner; D E Cameron
Journal:  Circulation       Date:  1993-11       Impact factor: 29.690

Review 8.  Spinal epidural hematoma in a hemophilic infant.

Authors:  I Noth; J J Hutter; P S Meltzer; M L Damiano; L P Carter
Journal:  Am J Pediatr Hematol Oncol       Date:  1993-02

9.  Antibodies that activate beta 2 integrins can generate different ligand binding states.

Authors:  S Ortlepp; P E Stephens; N Hogg; C G Figdor; M K Robinson
Journal:  Eur J Immunol       Date:  1995-03       Impact factor: 5.532

10.  Divalent cation regulation of the function of the leukocyte integrin LFA-1.

Authors:  I Dransfield; C Cabañas; A Craig; N Hogg
Journal:  J Cell Biol       Date:  1992-01       Impact factor: 10.539

View more
  18 in total

1.  Unraveling the Receptor-Ligand Interactions between Bladder Cancer Cells and the Endothelium Using AFM.

Authors:  Vinoth Sundar Rajan; Valérie M Laurent; Claude Verdier; Alain Duperray
Journal:  Biophys J       Date:  2017-03-28       Impact factor: 4.033

2.  Fibrin deposition following bile duct injury limits fibrosis through an αMβ2-dependent mechanism.

Authors:  Nikita Joshi; Anna K Kopec; Jessica L Ray; Holly Cline-Fedewa; Atta Nawabi; Timothy Schmitt; Rance Nault; Timothy R Zacharewski; Cheryl E Rockwell; Matthew J Flick; James P Luyendyk
Journal:  Blood       Date:  2016-02-26       Impact factor: 22.113

3.  Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies.

Authors:  Roheena Z Panni; John M Herndon; Chong Zuo; Samarth Hegde; Graham D Hogg; Brett L Knolhoff; Marcus A Breden; Xiaobo Li; Varintra E Krisnawan; Samia Q Khan; Julie K Schwarz; Buck E Rogers; Ryan C Fields; William G Hawkins; Vineet Gupta; David G DeNardo
Journal:  Sci Transl Med       Date:  2019-07-03       Impact factor: 17.956

4.  Protective Effects of Leukadherin1 in a Rat Model of Targeted Experimental Autoimmune Encephalomyelitis (EAE): Possible Role of P47phox and MDA Downregulation.

Authors:  Sara Hemmati; Mohammad Amin Sadeghi; Hasan Yousefi-Manesh; Mostafa Eslamiyeh; Ali Vafaei; Laleh Foroutani; Ghazaleh Donyadideh; AhmadReza Dehpour; Nima Rezaei
Journal:  J Inflamm Res       Date:  2020-07-31

5.  A Genetic Model of Constitutively Active Integrin CD11b/CD18.

Authors:  Laisel Martinez; Xiaobo Li; Gioser Ramos-Echazabal; Hafeez Faridi; Zachary M Zigmond; Nieves Santos Falcon; Diana R Hernandez; Serene A Shehadeh; Omaida C Velazquez; Vineet Gupta; Roberto I Vazquez-Padron
Journal:  J Immunol       Date:  2020-09-16       Impact factor: 5.422

6.  Fibrin(ogen) drives repair after acetaminophen-induced liver injury via leukocyte αMβ2 integrin-dependent upregulation of Mmp12.

Authors:  Anna K Kopec; Nikita Joshi; Holly Cline-Fedewa; Anna V Wojcicki; Jessica L Ray; Bradley P Sullivan; John E Froehlich; Brendan F Johnson; Matthew J Flick; James P Luyendyk
Journal:  J Hepatol       Date:  2016-12-10       Impact factor: 25.083

Review 7.  Pharmacological Tools to Activate Microglia and their Possible use to Study Neural Network Patho-physiology.

Authors:  Fernando Pena-Ortega
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

8.  Decoding Cytoskeleton-Anchored and Non-Anchored Receptors from Single-Cell Adhesion Force Data.

Authors:  Ediz Sariisik; Cvetan Popov; Jochen P Müller; Denitsa Docheva; Hauke Clausen-Schaumann; Martin Benoit
Journal:  Biophys J       Date:  2015-10-06       Impact factor: 4.033

9.  Protective effect of Xuebijing injection against acute lung injury induced by left ventricular ischemia/reperfusion in rabbits.

Authors:  Mingli Ji; Yuxia Wang; Lei Wang; Liping Chen; Jing Li
Journal:  Exp Ther Med       Date:  2016-04-20       Impact factor: 2.447

Review 10.  Can Integrin Agonists Have Cards to Play against Cancer? A Literature Survey of Small Molecules Integrin Activators.

Authors:  Alessandra Tolomelli; Paola Galletti; Monica Baiula; Daria Giacomini
Journal:  Cancers (Basel)       Date:  2017-07-05       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.